Cosette taps Rick Casten as CFO

Casten, who had stints at Baudax Bio, Lupin and Endo, said that he will support the transformation of Cosette through internal R&D and inorganic growth initiatives.
Sandra Levy
Senior Editor
Sandra Levy profile picture
rick casten
Rick Casten

Cosette Pharmaceuticals, a New Jersey-based specialty pharmaceutical company, is welcoming a new executive leader, Rick Casten, who is joining as chief financial officer.

“I am excited to have Rick Casten join our team, with his more than two decades of experience in helping drive long-term performance gains and financial growth,” said Apurva Saraf, president and CEO of Cosette.

“Rick joins Cosette at a pivotal inflection point for our business, accelerated by our transformative acquisition of eight commercial branded products from Daiichi Sankyo and the imminent launches of several new products,” Saraf said. “Cosette is well positioned to deliver on our diversification strategy while serving our customers and patients.”

[Read more: Cosette debuts generic Compazine]

apurva saraf
Apurva Saraf, president and CEO of Cosette

“I am excited to join the dedicated and successful team at Cosette at this pivotal moment in the company’s evolution,” Casten said. “With my highly complementary skill sets to those of my colleagues, we are well positioned to deliver industry leading growth, and I look forward to supporting the transformation of Cosette through internal R&D and inorganic growth initiatives.”

Casten has over 25 years of experience in pharmaceutical, bio-tech and Fortune 500 consumer products and public accounting. Prior to joining Cosette, he served as chief financial officer at Baudax Bio, a pharmaceutical company focused on innovative products for acute care settings.

Casten also served as vice president of finance, controller and treasurer at Lupin Pharmaceuticals, where he managed Lupin’s U.S. accounting operations and financial reporting, enforcing accounting policies and procedures. Earlier in his career, he served in various financial roles of increasing responsibilities at Endo Pharmaceuticals and Campbell Soup, and in public accounting, primarily at Ernst & Young.

[Read more: AAM makes 2 key appointments]

Casten earned his bachelor of science degree in business and economics, with a major in accounting, from Lehigh University and a master’s degree from the Johnson School at Cornell University. He is a certified public accountant in both Pennsylvania and California, and is a member of the American Institute of Certified Public Accountants and the Pennsylvania Institute of Certified Public Accountants.